Skip to content

Clinical and Functional Consequences of Photodynamic Diagnosis (PDD) and Intravesical Instillation Therapy

Clinical and Functional Consequences of Photodynamic Diagnosis (PDD) and Intravesical Instillation Therapy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04943094
Acronym
URODYN
Enrollment
50
Registered
2021-06-29
Start date
2019-09-01
Completion date
2025-12-31
Last updated
2023-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-muscle Invasive Bladder Cancer

Brief summary

The aim is to evaluate and compare treatment strategies for non-muscle invasive bladder cancer. Furthermore, the impact of intravesical instillations on bladder function will be examined by urodynamic examination both prior to and following instillation therapy.

Interventions

A urodynamic examination is performed in all patients four to six weeks following TURBT and repeated six months later in order to obtain bladder function and possible changes.

Sponsors

Aarhus University Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* non-muscle invasive bladder tumour

Exclusion criteria

* more than one previous bladder tumour recurrence * muscle invasive bladder cancer (at baseline or prior to inclusion) * utilization of urinary catheter * have had heart valve replacement performed * pregnant or lactating

Design outcomes

Primary

MeasureTime frameDescription
Change in urodynamic specifics (bladder compliance, detrusor overactivity, maximal cystometric capacity)examined at time 0 and after six monthsObtained from the urodynamic test

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026